Abstract
Immense progress has been made over the last century in medical diagnosis, especially in the techniques of radiological imaging. The evolution began in the mid-18908 by the epochal discoveries of Röntgen and Becquerel (Blaufox 1996). The initial limitation of radiology to observing externally radio-opaque structures such as bones in the living body rapidly evolved into functional imaging of organs such as kidney and liver and the circulatory system using radio-opaque contrast agents. With the advent of computed tomography soft tissues also became visible in high-resolution images, augmenting the spectrum of function studies of organ segments. Yet, the molecular-atomic level of biological organization in living tissues became observable only with the introduction of the radionuclide tracer technique by (1913). Further studies with radioactive and stable isotopes of common elements in organic compounds (C, H, O, N, S, P) in the 1930s and 1940s revealed the surprising extent to which both “functional” and “structural” compounds in the body are ceaselessly formed and broken down, even with no change in overall amount, form, or function (Schoenheimer 1946; Hevesy 1948). Today, the specialty of nuclear medicine is indispensable in clinical diagnosis and therapy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Antar MA, Spohr G, Herzog HH et al (1986) 15-(ortho-123-I-phenyl)-pentadecanoic acid, a new myocardial imaging agent for clinical use. Nucl Med Commun 7:683–696
Armbrecht JJ, Buxton DB, Schelbert HR (1990) Validation of [1-11-C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 81:1594–1605
Ballare E, Persana L, Lania AG et al (2001) Mutation of so-matostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment. J Clin Endocrinol Metab 86:3809–3814
Beckurts TE, Shreeve WW, Schieren R et al (1985) Kinetics of different 123I-and 14C-labeled fatty acids in normal and diabetic rat myocardium in vivo. Nuclear Med Commun 6:415–424
Bengel FM, Permanetter B, Ungerer M et al (2002) Alterations of the sympathetic nervous system and metabolic performance of the cardiomyopathic heart. Eur J Nucl Med Mol Imaging 29:198–202
Blaufox MD (1996) Becquerel and the discovery of radioactivity: early concepts. Semin Nucl Med XXVI:145–154
Boerman OC, Oyen WJG, Corstens FHM (2000) Radio-labeled receptor-binding peptides: a new class of radio-pharmaceuticals. Semin Nucl Med 30:195–208
Brown MA, Marshall DR, Sobel BE et al (1987) Delineation of myocardial oxygen utilization with carbon-11 labeled acetate. Circulation 76:687–696
DeGrazia JA, Ivanovich P, Fellows H et al (1965) A double isotope method for measurement of intestinal absorption of calcium in man. J Lab Clin Med 66:822–829
Delbeke D, Martin WH, Patton JA, Sandler M (eds) (2002) Practical FDG imaging, a teaching file. Springer, Berlin Heidelberg New York
De Meutter RC, Shreeve WW (1963) Conversion of DL-lac-tate-2-C14 or 3-C14 or pyruvate-2-C14 to blood glucose in humans: effects of diabetes, insulin, tolbutamide and glucose load. J Clin Invest 42:525–533
Ebert A, Feinendegen DL, Czech N et al (1993) Erfassung des Lipidstoffwechsels und der hepatozellulären Viabilität mittels 15-(para-123-J-Phenyl)-Pentadecansäure (pPPA) und 15-(ortho-131-J-Phenyl)-Pentadecansäure (oPPA) (abstract). Nuklearmedizin 32a:105
Feinendegen LE (1993) Single photon metabolic imaging in cardiology. In: Zaret BL, Beller GA (eds) Nuclear cardiology, state of the art and future directions, chap 24. Mos-by Year Book, St Louis, Mo
Feinendegen LE (2000) Myocardial imaging of lipid metabolism with labeled fatty acids. In: Dilsizian V (ed) Myocardial viability: a clinical and scientific treatise, chap 16. Futura, Armonk NY
Feinendegen LE, Ritzl F (1971) Insulin metabolism determination in vivo using iodine-125 and chromium-51 double labeling. Nucl Med (Stuttg) 9:748–751
Feinendegen LE, Heiniger HJ, Friedrich G et al (1973) Differences in reutilization of thymidine in hemopoietic and lymphopoietic tissues of the normal mouse. Cell Tissue Kinet 6:573–585
Feinendegen LE, Vyska K, Freundlieb C et al (1981) Non-invasive analysis of metabolic reactions in body tissues, the case of myocardial fatty acids. Eur J Nucl Med 6:191–200
Feinendegen LE, Henrich MM, Kuikka JT et al (1995) Myocardial lipid turnover in dilated cardiomyopathy: a dual in vivo tracer approach. J Nucl Cardiol 2:42–52
Feinendegen DL, Ohlenschlaeger U, Grossmann K et al (1996) Lipid metabolism in the liver studied in vivo with two isomers of labeled fatty acid analogs. J Nucl Med 37:1841–1845
Feinendegen LE, Herzog H, Thompson KH (2001) Cerebral glucose transport implies individualized glial cell function. J Cereb Blood Flow Metab 21:1160–1170
Firnau G, Garnett ES, Chan PK et al (1976) Intracerebral dopamine metabolism studied by a novel radioisotope technique. J Pharm Pharmacol 28:584–585
Fowler JS, Wolf AP, MacGregor RR et al (1988) Mechanistic positron emission tomography studies: demonstration of a deuterium isotope effect in the monoamine oxidase-catalyzed binding of C-11-deprenyl in living baboon brain. J Neurochem 51:1524–1534
Freundlieb C, Hoeck A, Vyska K et al (1978) Use of ω-123-I-labeled heptadecanoic acids for non-invasively measuring myocardial metabolism. In: Woldring M, Schmidt HAE (eds) Proceedings of the 15th international meeting of the Society of Nuclear Medicine, Groningen, 1977. Schattauer, Stuttgart, pp 216–219
Freundlieb C, Hoeck A, Vyska K et al (1980) Myocardial imaging and metabolic studies with (17-123-I) iodohep-tadecanoic acid. J Nucl Med 21:1943–1950
Friedrich G, Feinendegen LE, Heiniger HJ (1972) Studies on the incorporation of exogenic DNA in mammalian cells. Hoppe Seylers Z Physiol Chem 353:705–706
Gallagher BM, Ansari A, Atkins H et al (1977) Radiopharma-ceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. J Nucl Med 18:990–996
Gjedde A, Diemer NH (1983) Kinetic analysis of the uptake of glucose and some of its analogs in the brain using the single capillary model: comments on some points of controversy. In: Lambrecht RM, Rescigno A (eds) Lecture notes in biomathematics 48: Tracer kinetics and physiological modeling. Springer, Berlin Heidelberg New York, pp 387–410
Gruvberger S, Ringner M, Chen Y et al (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. J Cancer Res 61:5979–5984
Herzog H, Lele VR, Kuwert T et al (1990/1991) Changed pattern of regional glucose metabolism during yoga meditative relaxation. Neuropsychobiology 23:182–187
Hevesy G (1913) Radioelements as indicators in chemistry and physics. Chem News 108:166–167
Hevesy G (1948) Radioactive indicators. Interscience, New York
Hoeck A, Spohr G, Schmitz M et al (1986) 17-iodine-123 iodoheptadecanoic acid for metabolic liver studies in humans. J Nucl Med 27:1533–1539
Kaiser KP, Geuting B, Grossmann K et al (1990) Tracer kinetics of 15-(ortho-123-/131-I-phenyl)-pentadecanoic acid (oPPA) and 15-(para-123/131-I-phenyl)-pentadecanoic acid (pPPA) in animals and man. J Nucl Med 31:1608–1616
Kallie RN, Shreeve WW, Joubert SM (1968) Studies in primary hyperuricaemia III. The conversion of 14C to 14CO2 from glucose-1-14C and glucose-6-14C in hyperuricaemia and gout. S African Med J 42:473–476
Kelly DP, Mendelsohn NJ, Sobel BE et al (1993) Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilization (long-chain acyl-Co-A dehydrogenase deficiency). Am J Cardiol 71:738–744
Knapp FF Jr, Kropp J (1995) Iodine-123-labeled fatty acids for myocardial single photon emission tomography: Current status and future perspectives. Eur J Nucl Med 22:361–381
Kim EE, Yang DJ (eds) (2001) Targeted molecular imaging in oncology. Springer, Berlin Heidelberg New York
Landau BR, Chandramouli V, Schumann WC et al (1995) Estimates of Krebs cycle activity and contributions of gluconeogenesis to hepatic glucose production in fasting health subjects and IDDM patients. Diabetologia 38:831–838
Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423–451
Logan J, Fowler JD, Volkow ND et al (1990) Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740–747
Machulla H-J, Stoecklin G, Kupfernagel CH et al (1978) Comparative evaluation of fatty acids labeled with C-11, Cl-34m, Br-77, and I-123 for metabolic studies of the myocardium: concise communication. J Nucl Med 19:298–302
Machulla H-J, Marsmann M, Dutschka K et al (1980) Biochemical concept and synthesis of a radioiodinated phenylfatty acid for in vivo metabolic studies of the myocardium. Eur J Nucl Med 5:171–173
Maher BA (2001) Researchers focus on histone code. Scientist 15:15–16
Meyers DK, Feinendegen LE (1975a) Incorporation of thymidine and iododeoxyuridine into the DNA of mouse tissues. Can J Physiol Pharmacol 53:1014–1022
Meyers DK, Feinendegen LE (1975b) Double labeling with [3H]thymidine and [125I]iododeoxyuridine as a method for determining the fate of injected DNA and cells in vivo. J Cell Biol 67:484–488
Meyers DK, Feinendegen LE (1976) DNA turnover and thy-midine re-utilization in mouse tissues. Cell Tissue Kinet 9:215–221
Nyhan WL (1984) Nonketotic hyperglycinemia. In: Nyhan WL (ed) Abnormalities in amino acid metabolism in clinical medicine, chap 34. Appleton-Century-Croft, New York, pp 333–351
O’Brien KO, Zaveleta N, Caulfield LE et al (1999) Influence of prenatal iron and zinc supplements on supplemental iron absorption, red blood cell incorporation, and iron status in pregnant Peruvian women. Am J Clin Nutr 69:509–515
Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1–7
Phelps ME, Huang SC, Hoffman EJ et al (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6:371–388
Rader DJ, Schaefer JR, Lohse P et al (1993) Increased production of apolipoprotein A-l associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-l and lipoprotein Al in a patient with hyperal-phalipoproteinemia. Metab Clin Exp 42:1429–1434
Reivich M, Kuhl D, Wolf A et al (1979) The (18F)fluorodeox-yglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44:117–127
Rensberger B (1996) Life itself: exploring the realm of the living cell. Oxford University Press, Oxford
Ritzl F, Feinendegen LE (1971) In vivo determination of site and rate of insulin catabolism using the double tracer technique with 51-Cr and 131-I. In: Dynamic studies with radioisotopes in medicine. Proceedings of the Symposium on Dynamic Studies with Radioisotopes in Clinical Medicine and Research. International Atomic Energy Agency, Vienna, Austria, pp 57–68
Ritzl F, Feinendegen LE, Schnippering HG (1974) A double isotope technique for estimating insulin degradation in vivo. Nucl Med (Stuttg) 13:85–97
Ritz P, Coward WA (1995) Doubly labeled water measurement of total energy expenditure. Diabetes Metab 21:241–251
Rodwell VW (1996) Enzymes: kinetics. In: Murray RK, Granner DK, Mayes PA et al (eds) Harper’s biochemistry, 24th edn, chap 9. Appleton and Lange, Stamford, Conn, pp 75–90
Sasaki Y (1995) Carbon-14 and Carbon-13 breath tests. In: Wagner HN Jr, Szabo Z, Buchanan JW (eds) Principles of nuclear medicine, 2nd edn, chap 40. Saunders, Philadelphia, pp 958–965
Schelbert HR, Henze E, Sochor H et al (1986) Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction. Am Heart J 111:1055–1064
Schoenheimer R (1946) The dynamic state of body constituents. Harvard University Press, Cambridge, Mass, pp 1–78
Schroeder H, Schelbert HR (2000) Positron emission tomography for the assessment of myocardial viability: nonin-vasive approach to cardiac pathophysiology. In: Dilsizian V (ed) Myocardial viability: a clinical and scientific treatise, chap 17. Futura, Armonk, NY
Schultze B, Gregoire F, Hughes WL (1964) Renal uptake of pancreatic ribonuclease after intravenous injection in mice and rats. Technical Report, Brookhaven National Laboratory, Upton, NY, BNL-8683
Shapiro B, Gross MD, Sisson JS (1995) Neural crest tumors. In: Wagner HN Jr, Szabo Z, Buchanan JW (eds) Principles of nuclear medicine, 2nd edn, chap 33. Saunders, Philadelphia, pp 665–680
Shreeve WW, Cerasi E, Luft R (1970) Metabolism of (2-14C) pyruvate in normal, acromegalic and growth hormone-treated human subjects. Acta Endocrinol 65:155–169
Shreeve WW, Tashjian AJ, Oji N et al (1971) Formation of 14CO2 and 3H0H from glucose-1-14C-1-3H during oral cortisone glucose tolerance tests in obese patients. Metab Clin Exp 20:280–292
Shreeve WW, Schieren R, Machulla HJ et al (1984) Hepatic uptake and fate of 123I-and 14C-fatty acids in normal and ethanolic mice. Nucl Med Commun 5:519–524
Silverman DHS, Hoe CK, Seltzer MA et al (1998) Evaluating tumor biology and oncological disease with positron-emission tomography. Semin Rad Oncol 8:183–196
Smith SM, Wastney ME, Nyquist LE et al (1996) Calcium kinetics with microgram stable isotope doses and saliva sampling. J Mass Spectrom (CMB) 31:1265–1270
Sokoloff L, Reivich M, Kenney C et al (1977) The [14C]deoxyglucose method for the measurement of focal cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897–916
Stern MP (2000) Strategies and prospects for finding insulin resistance genes. J Clin Invest 106:323–327
Stryer L (1995) Enzymes: basic concepts and kinetics. In: Stryer L, Biochemistry, 4th edn, chap 8. Freeman, New York, pp 181–206
Syrota A, Merlet P, Delforge J (1995) The heart: clinical neu-rotransmission. In: Wagner HN Jr, Szabo Z, Buchanan JW (eds) Principles of nuclear medicine, 2nd edn, chap 37, sect 2. Saunders, Philadelphia, pp 759–773
Taylor SI (1995) Diabetes mellitus. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease I, 7th edn, chap 21. McGraw-Hill, NY, pp 843–896
Van Eenige MJ, Visser FC, Duwel CMB et al (1987) Analysis of myocardial time activity curves of I-123-heptadecanoic acid I. Curve fitting. Nucl Med 26:241–247
Wagner HN Jr (1995) Nuclear medicine: what it is, what it does. In: Wagner HN Jr, Szabo Z, Buchanan JW (eds) Principles of nuclear medicine, 2nd edn, chap 1. Saunders, Philadelphia, pp 1–8
Wagner HN, Burns HD, Dannais RF et al (1983) Imaging dopamine receptors in the human brain by positron tomography. Science 221:1264–1266
Wagner HN Jr, Szabo Z, Buchanan JW (eds) (1995) Principles of nuclear medicine, 2nd edn. Saunders, Philadelphia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Feinendegen, L.E., Shreeve, W.W., Wagner, H.N. (2003). Measurements of Biochemical Reactions In Vivo. In: Feinendegen, L.E., Shreeve, W.W., Eckelman, W.C., Bahk, YW., Wagner, H.N. (eds) Molecular Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55539-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-55539-8_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62427-8
Online ISBN: 978-3-642-55539-8
eBook Packages: Springer Book Archive